Panamera Holdings Corp. Files Q3 2024 10-Q

TL;DR

Panamera Holdings Corp. filed its 10-Q for the period ending 4/30/24. Check financials.

AI Summary

Panamera Holdings Corp. filed its 10-Q for the period ending April 30, 2024. The company, formerly known as Panamera Healthcare Corp, is incorporated in Nevada and operates in management consulting services. Its fiscal year ends on July 31st. The filing includes details on common stocks and various member types, such as DPVenturesMember and OfficerAndDirectorMember.

Why It Matters

This filing provides an update on Panamera Holdings Corp.'s financial status and corporate structure for the third quarter of fiscal year 2024, which is crucial for investors and stakeholders to assess the company's performance and outlook.

Risk Assessment

Risk Level: low — The filing is a routine quarterly report with no immediate red flags or significant negative disclosures.

Key Numbers

• 50000000 — Common Stocks (Number of common stocks outstanding as of April 30, 2024.)
• 550000000 — Common Stocks (Number of common stocks outstanding as of July 31, 2023.)
• 6000000 — Common Stocks (Number of common stocks outstanding as of April 30, 2023.)

Key Players & Entities

• Panamera Holdings Corp. (company) — Filer of the 10-Q
• Panamera Healthcare Corp (company) — Former name of the company
• 77056 (dollar_amount) — ZIP code for business and mailing address
• 713-878-7200 (dollar_amount) — Business phone number
• 0731 (dollar_amount) — Fiscal year end date
• 20240430 (date) — Conformed period of report

FAQ

Key Financial Figures

• $7,500,000 — rket prices on issuance date, valued at $7,500,000 and recognized a deposit for asset acqu
• $0.0001 — 0,000 shares of common stock, par value $0.0001per share. Prior management intended to

Filing Documents

• pnht_10q.htm (10-Q) — 621KB
• pnht_ex311.htm (EX-31.1) — 10KB
• pnht_ex312.htm (EX-31.2) — 10KB
• pnht_ex321.htm (EX-32.1) — 8KB
• 0001640334-24-001005.txt ( ) — 2389KB
• pnht-20240430.xsd (EX-101.SCH) — 26KB
• pnht-20240430_lab.xml (EX-101.LAB) — 151KB
• pnht-20240430_cal.xml (EX-101.CAL) — 31KB
• pnht-20240430_pre.xml (EX-101.PRE) — 117KB
• pnht-20240430_def.xml (EX-101.DEF) — 37KB
• pnht_10q_htm.xml (XML) — 232KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 3 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 12 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 17 Item 4.

Controls and Procedures

Controls and Procedures 17

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 19 Item 1A.

Risk Factors

Risk Factors 19 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 19 Item 3. Defaults Upon Senior Securities 19 Item 4. Mine Safety Disclosures 19 Item 5. Other Information 19 Item 6. Exhibits 20

SIGNATURES

SIGNATURES 21 2 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements PANAMERA HOLDINGS CORPORATION Consolidated Balance Sheets (Unaudited) April 30, July 31, 2024 2023 Assets Current Assets Cash $ 2,982 $ 118,569 Deposit for assets acquisition 7,548,000 - Accounts receivable held for sale - 8,333 Employee advanced - 2,700 Total Current Assets 7,550,982 129,602 Total Assets $ 7,550,982 $ 129,602 Liabilities and Stockholders' Deficit Current Liabilities Accounts payable and accrued liabilities $ 37,689 $ 32,385 Due to related party 72,648 47,499 Total Current Liabilities 110,337 79,884 Total Liabilities 110,337 79,884 Stockholders' Equity Preferred stock: 50,000,000 authorized; $ 0.0001 par value, no shares issued and outstanding - - Common stock: 550,000,000 authorized; $ 0.0001 par value, 51,410,000 shares and 41,410,000 shares issued at April 30, 2024 and July 31, 2023, respectively 5,141 4,141 Additional paid in capital 22,572,534 7,570,875 Common stock subscriptions receivable-related party - ( 2,000 ) Treasury stock, at cost: 6,000,000 shares at April 30, 2024 and July 31, 2023, respectively ( 600 ) ( 600 ) Accumulated deficit ( 15,136,430 ) ( 7,522,698 ) Total Stockholders' Equity 7,440,645 49,718 Total Liabilities and Stockholders' Equity $ 7,550,982 $ 129,602 The accompanying notes to the unaudited financial statements are an integral part of these statements. 3 Table of Contents PANAMERA HOLDINGS CORPORATION Consolidated Statements of Operations (Unaudited) For the For the Three Months Ended Nine Months Ended April 30, April 30, 2024 2023 2024 2023 Revenues $ - $ - $ - $ - Operating expenses Professional fees 7,537 8,919 54,021 22,138 General and administration expenses 7,501,483 1,320 7,561,997 4,057 Total operating expenses 7,509,020 10,239 7,616,018 26,195 Net loss from operations ( 7,509,020 ) ( 10,239 ) ( 7,

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This quarterly report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results. Our unaudited financial statements are prepared in accordance with United States Generally Accepted Accounting Principles. The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this quarterly report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this quarterly report. In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to "common shares" refer to the common shares

View Full Filing

View this 10-Q filing on SEC EDGAR